Oligonucleotides as inhibitors of protein synthesis.
Epa
W R
WR
Walter and Eliza Hall Institute of Medical Research, Royal Melbourne Hospital, Melbourne, Australia.
Barrett
G L
GL
Bartlett
P F
PF
D000818:Animals; D001692:Biological Transport; D002462:Cell Membrane / Q000378:metabolism; D002784:Cholesterol / Q000737:chemistry; D003505:Cyclodextrins / Q000737:chemistry; D015536:Down-Regulation; D009414:Nerve Growth Factors / Q000235:genetics* / Q000378:metabolism; D009474:Neurons / Q000378:metabolism; D016376:Oligonucleotides, Antisense / Q000138:chemical synthesis* / Q000378:metabolism / Q000494:pharmacology; D011107:Polylysine / Q000737:chemistry; D011500:Protein Synthesis Inhibitors / Q000138:chemical synthesis* / Q000378:metabolism / Q000494:pharmacology; D012333:RNA, Messenger / Q000096:biosynthesis; D051381:Rats; D017475:Receptors, Nerve Growth Factor / Q000235:genetics* / Q000378:metabolism; D013873:Thionucleotides / Q000138:chemical synthesis
D003505:Cyclodextrins; D009414:Nerve Growth Factors; D016376:Oligonucleotides, Antisense; D011500:Protein Synthesis Inhibitors; D012333:RNA, Messenger; D017475:Receptors, Nerve Growth Factor; D013873:Thionucleotides; D011107:Polylysine; D002784:Cholesterol